Navigation Links
Study Shows Use of AdvanDx's PNA FISH(TM) Test was Associated with an 82% Reduction in Intensive Care Unit Mortality Rates from Staphylococcus aureus Bloodstream Infections
Date:7/15/2008

cilitates the development of very simple, yet very accurate tests that don't require the extensive sample preparation necessary for other nucleic acid technologies.

PNA FISH tests enable microbiology labs to provide rapid and accurate identification of bloodstream pathogens directly from positive blood cultures in hours instead of days. Clinical studies show that rapid identification of bloodstream pathogens using PNA FISH tests leads to more appropriate patient therapy that saves lives and reduces unnecessary antibiotic use, patient length of stay and hospital costs.

About AdvanDx

AdvanDx is the world's leading provider of advanced molecular diagnostic products for the prevention, diagnosis and treatment of life-threatening, bacterial infections. AdvanDx's easy-to-use products provide fast and accurate results that enable dramatic improvements in patient care and help to save lives and reduce hospital costs.

AdvanDx's products employ standard laboratory techniques and equipment to reduce startup, implementation, technician and maintenance time, while providing fast results without sacrificing accuracy. Major medical centers, reference labs, government institutions and community hospitals throughout the United States, Europe and Asia rely on AdvanDx products as integral parts of their medical care.
For more information visit http://www.AdvanDx.com

CONTACTS:

Company Contact: Media Inquiries:

Joen T. Johansen Joe Romano

Director of Marketing Partner

AdvanDx HighGround, Inc.

+1-339-227-4052 +1-781-939-5800 Ext 208

jtj@advandx.com jromano@highgroundinc.com

References:

(1) Ly et al. Impact upon clinical outcomes of translation of PNA FSH-generated laboratory data from the cl
'/>"/>

SOURCE AdvanDx
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Nile Therapeutics Announces Dosing in Phase IIa Study of CD-NP in Heart Failure Patients
2. BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
3. Genmab A/S - Company Announcement: Recruitment Completed In Ofatumumab CLL Front Line Study
4. Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis
5. Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU
6. Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations
7. Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients Day
8. Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
9. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
10. Complete Study Results Comparing CTIs OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology
11. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2008)...mafore Pharmaceuticals Inc.,presented data at the ...es,in Cancer in Washington, D.C., announcing the d... that demonstrate significant anticancer,activity ...molecular scaffold has been developed using,comput...3 kinase inhibitors,as well as isoform-selective s...
(Date:8/26/2008)...FirstCall/ -- XTENT, Inc.,(Nasdaq: XTNT ) today a...,from the CUSTOM II trial was published in the mos...ntervention. The lead author of the article was,Dr...nter Utrecht, Utrecht,The Netherlands on behalf o...es across Europe., The one-year CUSTOM II trial, ...
(Date:8/25/2008)...nt Strategies--, PHILADELPHIA, Aug. 25 /PRNewswir...utations that are the main cause of the inherited ...addition, the researchers found,that the same muta...f,non-inherited neuroblastoma, the more common for...offer the first genetic tests to families,affected...
(Date:8/25/2008)...d Japanese Development Studies ...25 /- Genmab has,announced ...ic lymphocytic,leukemia and non-Hodgkin,s lymphoma... begin four studies of,ofatumumab in chronic lymph... lymphoma (NHL) this year., "Genmab and GSK have ...
Breaking Medicine Technology:Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 2XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 3XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention 4Gene That Causes Childhood Cancer Neuroblastoma Is Found 2Gene That Causes Childhood Cancer Neuroblastoma Is Found 3Gene That Causes Childhood Cancer Neuroblastoma Is Found 4Genmab Announces Upcoming Ofatumumab Studies 2Genmab Announces Upcoming Ofatumumab Studies 3Genmab Announces Upcoming Ofatumumab Studies 4Study finds no connection between vitamin D and overall cancer deaths 5032 1Study finds no connection between vitamin D and overall cancer deaths 5032 2Going live with click chemistry 1040 1Going live with click chemistry 1040 2Going live with click chemistry 1040 3Could hairy roots become biofactories 3F 1036 1Could hairy roots become biofactories 3F 1036 2Vincent Corso and Daniel Trush Win 2007 Avis We Try Harder Awards 5026 1Vincent Corso and Daniel Trush Win 2007 Avis We Try Harder Awards 5026 2Vincent Corso and Daniel Trush Win 2007 Avis We Try Harder Awards 5026 3
... data From 741-patient Trial Show Those Treated wi...mpact on Blood Pressure Compared,to Ibuprofen, EAS...ients with,osteoarthritis who also have controlled...rage daily blood pressure when treated with,the in...b compared,to a slight increase in those taking ib...
... Data to be Presented at the European League Again...tential Benefit of ofatumumab,in Patients With Rhe...Pennsylvania and COPENHAGEN,Denmark, June 15, 200...and Genmab A/S (CSE: GEN) announced today positive...be presented at EULAR,2007, the Annual European Co...
Other Medicine Technology:Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 2Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 3Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 4Lumiracoxib Study Showed Significantly Less Impact on Blood,Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 5GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 2GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 3GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 4GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 5
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...nataka is planning to enact legislation to make HI...d for politicians seeking to enter the state legis...ment on the need to bring in such a legislation wi...R. Ashok told IANS. Karnataka is one of six high-p...
...ers Novartis, is filing a petition against a court... its anti-cancer drugs. // What makes this news si...uality of life for an AIDS patient; a nightmare or... is backing its right to patent a modified version...
...en who wear a special kind of no-line bifocal lens... those who wear more conventional lenses according...ssue of Investigative Ophthalmology & Visual Scien...ng children with two myopic parents, myopia progre...
...al study led by Johns Hopkins suggests that the ra...haran Africa that HIV dementia along with Alzheime...ng the most common forms of dementia in the world....n the African continent using rigorous neurologica...
Other Medicine News:Health News:HIV Tests to Be Made Mandatory for Karnataka Couples, Politicians 2Health News:To Patent or Not-A Question of Life 2Health News:HIV Dementia Alarmingly High in Africa 2
LabWeb is a full-featured laboratory information system (LIS) with the added benefits only Psyche Systems can deliver - high ROI, a secure hosted offering and a true partnership. LabWeb features adva
LabPak POL Plus 2 Laboratory Information System
...e surgeon to view the patient, c-arm image intensi...ile field. , ,Electrocautery Cord and suction Tub...ng longer cord length sterility. , ,Extra large f...mmodates the larger incise area and can improve as...
...ealth will change the way you think about drapes a...and reduced reimbursements mean costs must be care... the quality of care or jeopardizing patient outco...pective of total value and long-term implications....
Medicine Products: